Chestnut Hill Health System — Philadelphia, Pennsylvania

Chestnut Hill Health System is a clinical research site located in Philadelphia, Pennsylvania, United States 19118.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Chestnut Hill Health System has participated in 3 clinical trials.

Therapeutic areas: Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma.

Sponsors: ETOP IBCSG Partners Foundation, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chestnut Hill Health System?

Chestnut Hill Health System has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chestnut Hill Health System conducted?

Chestnut Hill Health System has 3 clinical trials on record. Their work covers Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma.

Is Chestnut Hill Health System accredited by Crixeo Health?

Chestnut Hill Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chestnut Hill Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.